Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting
Erin M. Rock, Cheryl L. Limebeer, Roger G. Pertwee, et al.
Cannabis and Cannabinoid Research (2021)
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 88
Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders
Olivier J. Manzoni, Antonia Manduca, Viviana Trezza
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 1
The Pharmacokinetics and Pharmacodynamics of a Hemp-Derived “Full-Spectrum” Oral Cannabinoid Product with a 1:1 Ratio of Cannabidiol to Cannabidiolic Acid and Delta-9-Tetrahydrocannabinol to Delta-9-Tetrahydrocannabinolic Acid: A Double-Blind, Placebo-Controlled, Within-Subjects Human Laboratory Study
Harrison Elder, C. Austin Zamarripa, Mitchell Klausner, et al.
Cannabis and Cannabinoid Research (2025)
Closed Access | Times Cited: 1
Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
Ronit Vogt Sionov, Doron Steinberg
Biomedicines (2022) Vol. 10, Iss. 3, pp. 631-631
Open Access | Times Cited: 28
Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome
Stuart M. Brierley, Beverley Greenwood‐Van Meerveld, Giovanni Sarnelli, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 5-25
Closed Access | Times Cited: 26
Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations
Abdel-ilah Aziz, Long C. Nguyen, Loubna Oumeslakht, et al.
Cannabis and Cannabinoid Research (2022)
Closed Access | Times Cited: 23
Fetal cannabidiol (CBD) exposure alters thermal pain sensitivity, problem-solving, and prefrontal cortex excitability
Karli Swenson, Luis E. Gomez Wulschner, Victoria M. Hoelscher, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 8, pp. 3397-3413
Open Access | Times Cited: 14
Semi-Synthesis of Dimeric Cannabidiol Derivatives and Evaluation of their Affinity at Neurological Targets
Zachary I. Stryker, Jorge Iván Castillo-Arellano, Stephen J. Cutler, et al.
Journal of Natural Products (2025)
Closed Access
New Cannabinoids and Chlorin-Type Metabolites from the Flowers of Cannabis sativa L.: A Study on Their Neuroblastoma Activity
Nguyễn Quốc Tuấn, Hee Sung Park, Sung-Hoon Choi, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 521-521
Open Access
A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats
Jonathon C. Arnold, Cassandra V. Occelli Hanbury-Brown, Lyndsey L. Anderson, et al.
Neuropsychopharmacology (2024)
Open Access | Times Cited: 3
Cannabinoid drugs against chemotherapy-induced adverse effects: focus on nausea/vomiting, peripheral neuropathy and chemofog in animal models
Ana Bagüés, Yolanda López‐Tofiño, Alvaro Llorente‐Berzal, et al.
Behavioural Pharmacology (2022) Vol. 33, Iss. 2&3, pp. 105-129
Closed Access | Times Cited: 15
Cannabidiol for Oral Health: A New Promising Therapeutical Tool in Dentistry
Luigi Bellocchio, Assunta Patano, Alessio Danilo Inchingolo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9693-9693
Open Access | Times Cited: 8
Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats
Danielle Hen-Shoval, Lital Moshe, Talia Indig-Naimer, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3828-3828
Open Access | Times Cited: 7
Cannabidiol and Intestinal Motility: a Systematic Review
Galaxie Story, Carrie‐Ellen Briere, David Julian McClements, et al.
Current Developments in Nutrition (2023) Vol. 7, Iss. 10, pp. 101972-101972
Open Access | Times Cited: 4
Cannabidiolic acid activates the expression of the PPARβ/δ target genes in MDA-MB-231 cells
Masayo Hirao-Suzuki, Takayuki Koga, M Takiguchi, et al.
Archives of Biochemistry and Biophysics (2022) Vol. 731, pp. 109428-109428
Closed Access | Times Cited: 4
Plant Growth Promoting Potential of Rhizobacteria Isolated from Cannabis Sativa L.
Iqra Bano, Sana Tanveer, Basharat Ali
Pak-Euro Journal of Medical and Life Sciences (2022) Vol. 5, Iss. 2, pp. 291-300
Open Access | Times Cited: 4
Analyzing the medical use of cannabis for cancer patients: a critical perspective
Rushin Patel, Mrunal Patel, Zalak Patel, et al.
International Journal of Community Medicine and Public Health (2024) Vol. 11, Iss. 3, pp. 1349-1354
Open Access
Unraveling the molecular basis of cannabidiolic acid methyl Ester's anti-depressive effects in a rat model of treatment-resistant depression
Danielle Hen-Shoval, Talia Indig-Naimer, Lital Moshe, et al.
Journal of Psychiatric Research (2024) Vol. 175, pp. 50-59
Closed Access
Unleashing the therapeutic role of cannabidiol in dentistry
Sayem A Mulla, Amit Patil, Sheetal Mali, et al.
Journal of Oral Biology and Craniofacial Research (2024) Vol. 14, Iss. 5, pp. 649-654
Open Access
Cannabinoid hyperemesis syndrome: genetic susceptibility to toxic exposure
Ethan B. Russo, Venetia L. Whiteley
Frontiers in Toxicology (2024) Vol. 6
Open Access
Minor Cannabinoid Profile of Unregulated Cannabidiol Products
Erin M. Johnson, Michael Kilgore, Paul A. Nuzzo, et al.
Cannabis and Cannabinoid Research (2024)
Closed Access
Editorial: Cannabinoid interactions with ion channels, receptors, and the bio-membrane
Mohammad‐Reza Ghovanloo, Jonathon C. Arnold, Peter C. Ruben
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 1
Stimulants and Depressor Drugs in the Sleep-wake Cycle Modulation: The Case of Alcohol and Cannabinoids
Eric Murillo-Rodrı́guez, Cristina Carreón, Mario Eduardo Acosta-Hernández, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 15, pp. 1270-1279
Closed Access | Times Cited: 1
Cannabinoid-Based Medicines and Cancer Symptom Management
Paul Daeninck, Rachel Rudney, Mellar P. Davis
Springer eBooks (2022), pp. 129-152
Closed Access | Times Cited: 1
Medical use of cannabidiol and impact on cancer cell viability
Wesley M. Raup‐Konsavage, Kent E. Vrana
Elsevier eBooks (2023), pp. 335-347
Closed Access
Page 1 - Next Page

Scroll to top